Navigene is a company undertaking screening, diagnosis and research in Metabolomics along with helping laboratories and institutions across the world to implement its unique services.

Navigene strives for early and accurate prediction/diagnosis of disorders and ailments, through Preventive Genetic Screening solution for newborns, children and adults.

Navigene’s services in the segment are unique, robust, are made available at a very affordable price and implementable at a mass scale. The solutions offered by Navigene are highly customized and tailored to the need of the hospitals/labs/institutions/Clients/ Regions.

Navigene’s Flagship product NAVIGENE BABY SCREEN through its innovative and unique technology, screens the New born babies for 110 genetic and metabolic disorders as early as 3rd day of life using just a urine sample collected on a special filter paper. It is one of the most comprehensive screening tests in the world.

Navigene takes pride in being the first Indian company in the field of genetics and metabolomics to have exported its revolutionary technology and established a fully functional world class facility outside India catering to the entire south East Asia.

Navigene has successfully developed a unique model for overseas expansion and service delivery, this model enables Navigene to quickly roll out its services in association with strategic partner/laboratories in various countries and regions. This model has been successfully tested and deployed in our Joint Venture association in Hong Kong.